CXApp (CXAI) Q4 2025 Earnings Transcript

CXApp reported fiscal 2025 revenue of $4.6 million, down 36% year over year, but improved gross margin to 87% from 82% and cut net loss to $13.5 million from $19.4 million. Management said subscription revenue reached 98% of total sales, cash stood at $11.1 million, and 2026 should deliver double-digit growth driven by CXAI 2.0, new enterprise wins, and the TouchSource partnership. Offseting the positives, the company disclosed a NASDAQ bid-price delisting notice with an extension through September, keeping listing risk elevated.

Analysis

CXAI is transitioning from a low-quality revenue cleanup story into a financing-and-listing story with a product option embedded. The near-term equity setup is dominated less by growth optics than by whether the company can convert pipeline into contracted ARR fast enough to de-risk the NASDAQ bid-price issue before the September deadline; that creates a forced-feedback loop where any credible bookings print can matter disproportionately to the tape.

The second-order winner, if any, is not the company itself but adjacent infrastructure and platform providers that monetize AI buildout without single-name execution risk. CXAI’s emphasis on Google-based tooling, unified data fabrics, and enterprise integrations implies incremental spend on cloud, mapping, identity, and workplace software stacks; however, those vendors are diversified enough that this is not a tradeable revenue stream by itself. The real competitive dynamic is that CXAI is trying to pull procurement away from point solutions into bundled multi-year transformations, which raises ACV but also lengthens sales cycles and increases dependency on a few logo wins.

The market is likely underestimating the fragility of the “double-digit growth” framing because it is starting from a tiny base and may require only a handful of enterprise closes to look strong. That cuts both ways: if even one or two large deals slip a quarter, the narrative can unravel quickly, especially with ongoing dilution and listing risk. Conversely, if June product launch plus the TouchSource channel yields a visible bookings inflection, the stock can re-rate sharply because fixed costs are now lower and incremental gross profit drops through at a much higher rate than before.

My contrarian view is that this is a plausible product story but a weak public-equity setup until the company proves repeatable conversion, not just pipeline language. The right way to play it is event-driven, not thematic: you want confirmation in the next 30-60 days, or you fade rallies into the delisting overhang and execution risk. The asymmetry is still positive for a small-size speculative long, but only if position sizing reflects binary downside from compliance failure or another quarter of missed bookings.

Key Decisions for Investors

• Small speculative long CXAI only as an event trade into June CXAI 2.0 launch / next earnings, sized <25 bps NAV; thesis is a bookings inflection that can compress listing-risk discount, but exit quickly if no contract conversion is disclosed.
• Buy CXAI call spreads instead of common stock for the next 2-3 months if liquidity allows; upside is a sharp re-rate on any credible enterprise win, while downside is capped if the delisting narrative persists.
• Pair trade: long a diversified enterprise AI beneficiary (GOOGL) vs short CXAI as a quality-vs-story expression if you want exposure to AI spend without single-name compliance risk; hold 1-3 months until CXAI proves conversion.
• Avoid initiating a short until after the September NASDAQ deadline window, unless bid-price compliance deteriorates further; forced short squeezes are possible on any deal announcement, making the borrow poor asymmetrically.
• Use a tight risk budget and predefine a thesis break: if the next update does not show at least one visible multi-year enterprise win or channelized deployment, cut exposure immediately rather than averaging down.